Abstrax Helps BHO Extraction Remain Legal in Canada
“…we dove into meticulous research and evidence-based arguments to help the legislature understand the reality of the (BHO Extraction) situation, while driving home the plethora of health and wellness benefits that come with the process.” – Kevin Koby, CSO of ABSTRAX
TUSTIN, Calif. (PRWEB)
June 20, 2023
ABSTRAX, an industry leader in the study and production of cannabis and botanically-derived terpenes, has officially released a white paper detailing the company’s role in 2017 in preventing the prohibition of hydrocarbon extraction (including BHO extraction) in Canada.
To accomplish this, Kevin Koby, Chief Science Officer (CSO) and Co-Founder of ABSTRAX, and his team, alongside industry partners ETS and Hollistek, presented a compelling case that emphasizes the necessity for regulatory oversight while addressing concerns regarding illicit production and the safety of producers and consumers.
The BHO (Butane Hash Oil) extraction method has been often targeted by legislators as being dangerous due to risks associated with handling flammable and volatile substances such as butane gas. Without proper oversight and training, extractors can be exposed to dangerous contaminants within poorly ventilated rooms and be injured due to uncontrolled pressure during the process.
“While there are inherent dangers involved, BHO will never go away,” said Koby. “In fact, if made illegal extractors will continue to use the method and skirt safety practices. Knowing this, we dove into meticulous research and evidence-based arguments to help the legislature understand the reality of the situation, while driving home the plethora of health and wellness benefits that come with the process.”
Hydrocarbon extraction allows producers to capture and preserve the full spectrum of cannabinoids and terpenes found in cannabis, resulting in extracts that offer enhanced potency and flavor profiles. Health benefits of concentrated cannabis extracts are used for pain management, anxiety and stress relief, appetite stimulation – and are even thought to have important neuroprotective properties.
To chronicle this important milestone in ABSTRAX’s history and the research that led Canadian legislators to choose regulation over banning BHO extraction, ABSTRAX has released a whitepaper that can be accessed at the following link: https://abstraxtech.com/pages/terpene-research.
“ABSTRAX remains committed to driving innovation and advancing the cannabis industry through its relentless pursuit of excellence in extraction, formulation, and research,” said Koby. “By taking the lead in educating the Canadian government and advocating for the continued legality and regulation of hydrocarbon extraction, we’re showcasing our dedication to fostering a safe, transparent, and thriving cannabis market.”
About ABSTRAX
Leveraging its proven background in cannabis research, ABSTRAX is the leader in the research, development, and production of botanically-derived and cannabis-inspired terpenes that create unforgettable sensorial experiences. Headquartered in California, the company owns and operates a state-of-the-art type 7 licensed research and manufacturing lab where it’s award-winning product developers and scientists leverage the most advanced strain analysis technology to extract and study aroma compounds via three-dimensional analysis, allowing for each and every compound within a plant to be named and studied. The company has partnered with many of the best cultivators in the industry to study their cannabis profiles and create the world’s most advanced terpene formulations. As a result of its efforts, ABSTRAX offers the largest terpene catalog of the most popular strains – botanically-derived terpene blends and isolates native to cannabis. These ingredients, also known as functional flavors and aromas, are used in vapes, concentrates, edibles, beer, essential oils, fragrances, cosmetics, topicals, tinctures, alcohol, food and beverage, personal care, and more. The company works with internationally recognized brands and provides unparalleled cannabis research, innovation, and custom formulations to create products that engage and thrill consumers. ABSTRAX also devotes significant resources to developing the highest terpene standards and best practices in the industry. The company has developed a robust quality management system including Gas Chromatography analysis and molecular distillation of natural ingredients to achieve the highest purity standards. Investigating and ensuring that ingredients used in its own products, and products within its industry, are safe for consumption. The terpene industry is a rapidly growing segment of the global flavor and fragrance market, which is expected to grow to $35 billion by 2024. This market segment includes the cannabis, CBD, skincare, cosmetics, health and wellness, food and beverage industries. For more information, visit AbstraxTech.com.
Share article on social media or email: